Delfi Diagnostics, Inc. of Palo Alto, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-25. The offering totals $225.0M, of which $225.0M was reported sold. Industry: Biotechnology.
Showing 25 of 28 people.
| Name | Role | Location |
|---|---|---|
| Michael Dybbs | Director | Half Moon Bay, CA |
| Rishi Gupta | Director | New York, NY |
| Elizabeth Homans | Director | Baltimore, MD |
| Justin Kao | Director | Baltimore, MD |
| Jacob Van Naarden | Director | Baltimore, MD |
| Victor Velculescu | Director | Baltimore, MD |
| Greg Yap | Director | CAMBRIDGE, MA |
| Peter Bach | Executive Officer | Baltimore, MD |
| Jennifer Buechel | Executive Officer | Baltimore, MD |
| Nicholas Dracopoli | Executive Officer | Baltimore, MD |
| Douglas Schenkel | Executive Officer | Baltimore, MD |
| Victor Velculescu | Executive Officer | Baltimore, MD |
| Victor Velculescu | Promoter | Baltimore, MD |
| Peter B Bach | Executive Officer | Palo Alto, CA |
| Lee-Ann B Smith-Freeman | Executive Officer | Palo Alto, CA |
| Victor B Velculescu | Director | Palo Alto, CA |
| Susan Tousi | Director | Palo Alto, CA |
| Susan Tousi | Executive Officer | Palo Alto, CA |
| Amoolya B Singh | Executive Officer | Palo Alto, CA |
| Elizabeth B Homans | Director | Palo Alto, CA |
| Rishi B Gupta | Director | Palo Alto, CA |
| Jacob B Van Naarden | Director | Palo Alto, CA |
| Michael B Dybbs | Director | Palo Alto, CA |
| Greg B Yap | Director | Palo Alto, CA |
| Justin B Kao | Director | Palo Alto, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-12-18 | D | $60.0M | $34.3M |
| 2021-01-27 | D | $101.1M | $101.1M |
| 2019-08-27 | D | $5.5M | $5.5M |
| 2019-08-13 | D | $15K | $15K |